Alzheimers and Dementia

Meditation and music may improve memory of those at-risk for Alzheimer’s Disease

September is World Alzheimer’s Month, and subjective cognitive decline, or SCD, can be a warning sign for the disease. Symptoms can include losing one’s train of thought, forgetting the content of a movie soon after the credits roll and feeling overwhelmed when making plans or coordinating events. Kim Innes, an epidemiology professor from the West Virginia University School of Public Health, and her team are studying the potential benefits of a simple meditation or
Alzheimers and Dementia cancer Neurodegenerative diseases Neurology

New Clinical Trial Will Test Cancer Drug As Alzheimer’S Treatment

The Alzheimer’s Drug Discovery Foundation (ADDF) announces a $2.1 million grant awarded to R. Scott Turner, MD, PhD, of Georgetown University Medical Center to conduct a phase II clinical trial of low-dose nilotinib (marketed as Tasigna® for use as a cancer therapy) in patients with Alzheimer’s disease. Nilotinib is an FDA-approved drug for the treatment of adult chronic myeloid leukemia. In preclinical studies conducted by Georgetown researchers, nilotinib reduced cognitive